This company has been marked as potentially delisted and may not be actively trading. OTCMKTS:ALXA ALXA (ALXA) Stock Price, News & Analysis Add Share Share Stock Analysis Stock AnalysisBuy This Stock About ALXA Stock (OTCMKTS:ALXA) 30 days 90 days 365 days Advanced Chart Get ALXA alerts:Sign Up Key Stats Today's Range$0.94▼$0.9450-Day Range N/A52-Week Range$0.22▼$1.60Volume100 shsAverage Volume158,340 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Alexza Pharmaceuticals, Inc. is a pharmaceutical company focused on the research, development and commercialization of products for the acute treatment of central nervous system conditions. The Company's product candidates are based on the Staccato system technology. Its product candidates in development include AZ-002, which contains alprazolam as an active pharmaceutical ingredient (API) is developed for the management of patients with acute repetitive seizures, and AZ-007, which contains zaleplon as API is developed for the treatment of insomnia in patients who have difficulty falling asleep, including those patients with middle of the night awakening having difficulty falling back asleep. Its product also includes ADASUVE, which contains loxapine as API is developed for the treatment of agitation associated with schizophrenia or bipolar disorder. It has initiated a Phase IIa proof-of-concept study for AZ-002 in patients with epilepsy and has completed Phase I testing for AZ-007. Read More Receive ALXA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ALXA and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ALXA Stock News HeadlinesAlexa Chung just revisited one of her favourite coat styles - and the traditional cover-up looks better than everSeptember 7 at 7:36 PM | msn.comAlexa Chung pairs a grapefruit pink Chloé gown with this season's boldest shoe trendSeptember 6 at 7:53 AM | yahoo.comAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.September 8 at 2:00 AM | Porter & Company (Ad)Ronda Rousey Reveals The Main Reason She Faced Alexa Bliss In WWESeptember 5 at 10:49 PM | msn.comAlexa Bliss Seemingly Responds to Ronda Rousey’s Remarks About Their FeudSeptember 5 at 10:49 PM | msn.comMJF responds to Ronda Rousey’s very dumb take on Alexa BlissSeptember 4, 2025 | sports.yahoo.comPsychic Medium Matt Fraser and Wife Alexa Are Expecting Baby No. 3 Less Than One Year After Welcoming Second Son (Exclusive)September 3, 2025 | msn.comSmart Speaker, Smart Beagle: Dog Uses Alexa To Play His Favorite SongsSeptember 3, 2025 | msn.comSee More Headlines ALXA Stock Analysis - Frequently Asked Questions How were ALXA's earnings last quarter? ALXA (OTCMKTS:ALXA) announced its quarterly earnings data on Wednesday, May, 11th. The healthcare company reported ($0.16) earnings per share for the quarter. The healthcare company had revenue of $0.72 million for the quarter. What other stocks do shareholders of ALXA own? Based on aggregate information from My MarketBeat watchlists, some other companies that ALXA investors own include Anavex Life Sciences (AVXL), Pernix Therapeutics (PTX), BioDelivery Sciences International (BDSI), PayPal (PYPL), Achillion Pharmaceuticals (ACHN), Bank of America (BAC) and Bristol Myers Squibb (BMY). Company Calendar Last Earnings5/11/2016Today9/08/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorN/A Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:ALXA Previous SymbolNASDAQ:ALXA CIK1344413 Webwww.alexza.com Phone+1-650-9447000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (OTCMKTS:ALXA) was last updated on 9/8/2025 by MarketBeat.com Staff From Our PartnersCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALXA Please log in to your account or sign up in order to add this asset to your watchlist. Share ALXA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
